| Medical and Health Sciences | 2021-2025 | 171 | US 65 | 99.97 |
| Cardiology and Cardiovascular Medicine | Lifetime | 667 | US 350 | 98.82 |
| Complementary and Alternative Medicine | Lifetime | 748 | US 259 | 93.09 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 32 | US 20 | 99.87 |
| Surgery | 2021-2025 | 108 | US 47 | 99.37 |
| Complementary and Alternative Medicine | 2021-2025 | 19 | US 5 | 99.03 |
| Epidemiology | 2021-2025 | 534 | US 179 | 95.15 |
| Biomedical Engineering | 2021-2025 | 990 | US 82 | 93.06 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 640 | US 220 | 92.29 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 330 | US 133 | 91.95 |
| Oncology | 2021-2025 | 834 | US 352 | 86.08 |
| Cardiovascular Function and Risk Factors | Lifetime | 917 | US 451 | 98.47 |
| Heart Failure Treatment and Management | Lifetime | 469 | US 226 | 98.29 |
| Cardiac pacing and defibrillation studies | Lifetime | 545 | US 277 | 98.41 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 308 | US 140 | 97.08 |
| Heart Rate Variability and Autonomic Control | Lifetime | 994 | US 436 | 97.21 |
| Mechanical Circulatory Support Devices | Lifetime | 821 | US 459 | 97.02 |
| Hemodynamic Monitoring and Therapy | Lifetime | 690 | US 280 | 96.47 |
| Potassium and Related Disorders | Lifetime | 256 | US 127 | 95.04 |
| Vagus Nerve Stimulation Research | Lifetime | 561 | US 226 | 85.35 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 10 | US 2 | 99.43 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 23 | US 11 | 99.60 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 52 | US 28 | 99.67 |
| Cardiovascular and exercise physiology | 2021-2025 | 19 | US 6 | 99.23 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 22 | US 6 | 98.78 |
| Heart Failure Treatment and Management | 2021-2025 | 48 | US 25 | 99.57 |
| Mechanical Circulatory Support Devices | 2021-2025 | 78 | US 37 | 98.48 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 138 | US 39 | 98.65 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 126 | US 67 | 98.02 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 28 | US 8 | 96.94 |
| Electrolyte and hormonal disorders | 2021-2025 | 34 | US 11 | 95.89 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 436 | US 117 | 96.88 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 261 | US 102 | 95.72 |
| Cardiac Health and Mental Health | 2021-2025 | 163 | US 59 | 94.55 |
| Potassium and Related Disorders | 2021-2025 | 43 | US 22 | 96.33 |
| Diabetes Treatment and Management | 2021-2025 | 548 | US 194 | 94.36 |
| Cardiac Arrest and Resuscitation | 2021-2025 | 880 | US 318 | 92.47 |
| Lymphatic System and Diseases | 2021-2025 | 124 | US 51 | 89.33 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 502 | US 125 | 87.42 |
| Acute Myocardial Infarction Research | 2021-2025 | 830 | US 199 | 90.87 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 150 | US 50 | 86.21 |
| Renal function and acid-base balance | 2021-2025 | 131 | US 44 | 82.61 |
| Non-Invasive Vital Sign Monitoring | 2021-2025 | 760 | US 114 | 83.64 |
| Vagus Nerve Stimulation Research | 2021-2025 | 256 | US 88 | 77.10 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 890 | US 398 | 76.71 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 965 | US 300 | 64.63 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 666 | US 164 | 39.44 |
